Literature DB >> 16406700

Holding T cells in check--a new role for complement regulators?

M Paula Longhi1, Claire L Harris, B Paul Morgan, Awen Gallimore.   

Abstract

Complement is not only part of the innate immune system, but has also been implicated in adaptive immunity. The role of complement and its regulatory proteins in modulating T cell activity has been the focus of several recent studies. These, which have included work on the membrane co-factor protein (MCP or CD46), decay accelerating factor (DAF or CD55) and CD59, indicate that complement regulators can influence the proliferative capacity of T cells and their ability to produce cytokines, influencing the outcome of a T cell response to a given antigen. Here we review these studies, which reveal another important link between the innate and the adaptive immune system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16406700     DOI: 10.1016/j.it.2005.12.008

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  44 in total

1.  Reduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1/Th17 differentiation.

Authors:  Qing Ma; Dan Li; Roza Nurieva; Rebecca Patenia; Roland Bassett; Wei Cao; Andrei M Alekseev; Hong He; Jeffrey J Molldrem; Michael H Kroll; Richard E Champlin; George E Sale; Vahid Afshar-Kharghan
Journal:  Biol Blood Marrow Transplant       Date:  2012-06-01       Impact factor: 5.742

Review 2.  Complement: a key system for immune surveillance and homeostasis.

Authors:  Daniel Ricklin; George Hajishengallis; Kun Yang; John D Lambris
Journal:  Nat Immunol       Date:  2010-08-19       Impact factor: 25.606

Review 3.  Overview of the immune response.

Authors:  David D Chaplin
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

4.  Ligation of the cell surface receptor, CD46, alters T cell polarity and response to antigen presentation.

Authors:  Jane Oliaro; Anupama Pasam; Nigel J Waterhouse; Kylie A Browne; Mandy J Ludford-Menting; Joseph A Trapani; Sarah M Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

5.  Levels of expression of complement regulatory proteins CD46, CD55 and CD59 on resting and activated human peripheral blood leucocytes.

Authors:  Stephen E Christmas; Claudia T de la Mata Espinosa; Deborah Halliday; Cheryl A Buxton; Joanne A Cummerson; Peter M Johnson
Journal:  Immunology       Date:  2006-09-26       Impact factor: 7.397

Review 6.  Complement-targeted therapeutics.

Authors:  Daniel Ricklin; John D Lambris
Journal:  Nat Biotechnol       Date:  2007-11       Impact factor: 54.908

7.  CD59 but not DAF deficiency accelerates atherosclerosis in female ApoE knockout mice.

Authors:  Guipeng An; Takashi Miwa; Wen-Liang Song; John A Lawson; Daniel J Rader; Yun Zhang; Wen-Chao Song
Journal:  Mol Immunol       Date:  2009-03-17       Impact factor: 4.407

8.  Upregulated expression of complement inhibitory proteins on bladder cancer cells and anti-MUC1 antibody immune selection.

Authors:  Juan Carlos Varela; Carl Atkinson; Robert Woolson; Thomas E Keane; Stephen Tomlinson
Journal:  Int J Cancer       Date:  2008-09-15       Impact factor: 7.396

9.  The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease.

Authors:  T Sugihara; A Kobori; H Imaeda; T Tsujikawa; K Amagase; K Takeuchi; Y Fujiyama; A Andoh
Journal:  Clin Exp Immunol       Date:  2010-01-19       Impact factor: 4.330

Review 10.  T-cell regulation by CD46 and its relevance in multiple sclerosis.

Authors:  Anne L Astier
Journal:  Immunology       Date:  2008-04-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.